Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pran Kishore Deb

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|June 25, 2019
Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine ReceptorsPran Kishore Deb
Current Pharmaceutical Design|October 12, 2019
Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine ReceptorsPran Kishore Deb
Current Pharmaceutical Design|November 2, 2019
Therapeutic Potentials of Adenosine Receptors: The State of The ArtPran Kishore Deb
AAPS Pharmscitech|April 2, 2026
Polymer Drug Conjugate: A Revolution in Drug DeliveryChandan Kumar Singh, Pran Kishore Deb
European Journal of Medicinal Chemistry|February 10, 2012
Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agentsAlka Bali, Ruchika Ohri, Pran Kishore Deb
RSC Advances|June 18, 2025
Therapeutic potential of adenosine receptor modulators in cancer treatmentPrasenjit Maity, Swastika Ganguly, Pran Kishore Deb
Current Medicinal Chemistry|January 8, 2025
An Azomethine Derivative, 1-(4-nitrophenyl)-N-phenylmethanimine (BCS2) Ameliorated 7,12-dimethylbenz(a)anthracene-induced Mammary Carcinoma through Nrf2-Keap1-HO-1 PathwayReetuparna Acharya, Pran Kishore Deb, Shakti Prasad Pattanayak
Inflammopharmacology|February 20, 2026
Azilsartan prevents central modulation of BDNF and PPARγ in Alzheimer's pathology through amyloidogenic and inflammatory pathways: experimental and computational evidenceVarnita Karmakar, Arya Ghosh, Pran Kishore Deb, et al.
Current Pharmaceutical Design|October 2, 2024
Design of Novel Imidazole Derivatives as Potential Non-nucleoside Reverse Transcriptase Inhibitors using Molecular Docking and Dynamics StrategiesPriyanka Chandra, Swastika Ganguly, Pran Kishore Deb, et al.
Current Pharmaceutical Design|November 13, 2020
Heparanase Inhibitors in Cancer Progression: Recent AdvancesRajwinder Kaur, Pran Kishore Deb, Vishal Diwan, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|June 25, 2019
Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine ReceptorsPran Kishore Deb
Current Pharmaceutical Design|October 12, 2019
Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine ReceptorsPran Kishore Deb
Current Pharmaceutical Design|November 2, 2019
Therapeutic Potentials of Adenosine Receptors: The State of The ArtPran Kishore Deb
AAPS Pharmscitech|April 2, 2026
Polymer Drug Conjugate: A Revolution in Drug DeliveryChandan Kumar Singh, Pran Kishore Deb
European Journal of Medicinal Chemistry|February 10, 2012
Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agentsAlka Bali, Ruchika Ohri, Pran Kishore Deb
RSC Advances|June 18, 2025
Therapeutic potential of adenosine receptor modulators in cancer treatmentPrasenjit Maity, Swastika Ganguly, Pran Kishore Deb
Current Medicinal Chemistry|January 8, 2025
An Azomethine Derivative, 1-(4-nitrophenyl)-N-phenylmethanimine (BCS2) Ameliorated 7,12-dimethylbenz(a)anthracene-induced Mammary Carcinoma through Nrf2-Keap1-HO-1 PathwayReetuparna Acharya, Pran Kishore Deb, Shakti Prasad Pattanayak
Inflammopharmacology|February 20, 2026
Azilsartan prevents central modulation of BDNF and PPARγ in Alzheimer's pathology through amyloidogenic and inflammatory pathways: experimental and computational evidenceVarnita Karmakar, Arya Ghosh, Pran Kishore Deb, et al.
Current Pharmaceutical Design|October 2, 2024
Design of Novel Imidazole Derivatives as Potential Non-nucleoside Reverse Transcriptase Inhibitors using Molecular Docking and Dynamics StrategiesPriyanka Chandra, Swastika Ganguly, Pran Kishore Deb, et al.
Current Pharmaceutical Design|November 13, 2020
Heparanase Inhibitors in Cancer Progression: Recent AdvancesRajwinder Kaur, Pran Kishore Deb, Vishal Diwan, et al.
Pageof 8